{"id":"W2066046508","doi":"10.1111/j.1463-1326.2010.01251.x","title":"A placebo‐controlled trial of exenatide twice‐daily added to thiazolidinediones alone or in combination with metformin","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"Professional Engineers Ontario","funders":"Amylin Pharmaceuticals; Eli Lilly and Company","keywords":"Exenatide; Placebo; Metformin; Medicine; Internal medicine; Clinical endpoint; Type 2 diabetes; Nausea; Adverse effect; Gastroenterology; Diabetes mellitus; Randomized controlled trial; Endocrinology; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007623037,0.000240649,0.001056068,0.0004451099,0.00005424963,0.00002724053,0.00009427275,0.00010073,0.00006264568],"category_scores_gemma":[0.0003664884,0.0001551515,0.00009171156,0.0003861477,0.00007047025,0.0002046385,0.00006404243,0.0001730584,0.000008130482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001404098,"about_ca_system_score_gemma":0.00005803845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004710825,"about_ca_topic_score_gemma":0.0002028627,"domain_scores_codex":[0.9985397,0.00006260771,0.0004171814,0.0003023566,0.0003465426,0.0003315829],"domain_scores_gemma":[0.9990425,0.0002181683,0.0001597859,0.0002795734,0.0001197482,0.0001801858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7203039,0.01631375,0.07664713,0.001104003,0.003353721,0.0001190032,0.004283996,0.00001153858,0.0713384,0.02498578,0.001476348,0.08006246],"study_design_scores_gemma":[0.7944591,0.00314716,0.1555973,0.0001953407,0.001730125,0.000002366305,0.000220524,0.0002239474,0.03585461,0.0006284298,0.007533907,0.0004071849],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937972,0.0002496261,0.00001541168,0.0006926638,0.0002970979,0.003656404,0.000007716707,0.00004441137,0.001239449],"genre_scores_gemma":[0.9944755,0.0001025975,0.00301597,0.0003432224,0.0001209477,0.000515848,0.00003271304,0.00002043468,0.001372716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07965527,"threshold_uncertainty_score":0.6326896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008773329220469896,"score_gpt":0.2375963732448478,"score_spread":0.2288230440243779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}